For now Covaxin likely to be only Covid vaccine available for children of 15-18 yrs
New Delhi Dec 26 PTI Bharat Biotechs Covaxin is likely to be the only COVID-19 vaccine available for now for children in the age group of 15-18 years who will be inoculated from January 3 official sources saidAlso healthcare and frontline workers and citizens above 60 years of age with comorbidities would be administered the third dose of the same vaccine they had been given beforePrime Minister Narendra Modi in a televised address to the nation on Saturday night announced that vaccination against COVID-19 for children between 15-18 years will start from January 3while precaution dose for healthcare and frontline workers would be administered from January 10The decisions came amid rising Covid cases linked to the Omicron variant of the virusThe precaution dose will also be available for citizens above 60 years of age and with comorbidities on the advice of their doctor from January 10 next year as well the prime minister had saidBharat Biotechs Covaxin is the only COVID-19 vaccine which will be administered for now to children in the age group of 15-18 years who will be inoculated from January 3 The estimated population to be covered in this category is seven to eight crores an official source saidThe source said that Zydus Cadilas vaccine ZyCoV-D has not yet been introduced in the countrys inoculation programme even for adults though it had received emergency use authorisation from the drug regulator on August 20 making it the first vaccine that could be administered in the age group of 12-18 years in the countryThe indigenously developed ZyCoV-D is the worlds first DNA-based needle-free COVID-19 vaccineThe gap between the second and third dose of COVID-19 vaccine which is being termed as precaution dose is likely to be nine to 12 monthsNecessary modifications are being done on the CoWIN portal to register the new category of vaccinationThe Drugs Controller General of India DCGI granted emergency use authorisation to indigenously-developed Covaxin for children above 12 years with certain conditions on FridayMore than 61 per cent of Indias adult population has received both doses of the vaccine Similarly about 90 per cent of the adult population has received the first dose of Covid vaccineThe cumulative COVID-19 vaccine doses administered in the country has exceeded 141 crore PTI PLB ANB ANB
New Delhi Dec 26 PTI Bharat Biotechs Covaxin is likely to be the only COVID-19 vaccine available for now for children in the age group of 15-18 years who will be inoculated from January 3 official sources saidAlso healthcare and frontline workers and citizens above 60 years of age with comorbidities would be administered the third dose of the same vaccine they had been given beforePrime Minister Narendra Modi in a televised address to the nation on Saturday night announced that vaccination against COVID-19 for children between 15-18 years will start from January 3while precaution dose for healthcare and frontline workers would be administered from January 10The decisions came amid rising Covid cases linked to the Omicron variant of the virusThe precaution dose will also be available for citizens above 60 years of age and with comorbidities on the advice of their doctor from January 10 next year as well the prime minister had saidBharat Biotechs Covaxin is the only COVID-19 vaccine which will be administered for now to children in the age group of 15-18 years who will be inoculated from January 3 The estimated population to be covered in this category is seven to eight crores an official source saidThe source said that Zydus Cadilas vaccine ZyCoV-D has not yet been introduced in the countrys inoculation programme even for adults though it had received emergency use authorisation from the drug regulator on August 20 making it the first vaccine that could be administered in the age group of 12-18 years in the countryThe indigenously developed ZyCoV-D is the worlds first DNA-based needle-free COVID-19 vaccineThe gap between the second and third dose of COVID-19 vaccine which is being termed as precaution dose is likely to be nine to 12 monthsNecessary modifications are being done on the CoWIN portal to register the new category of vaccinationThe Drugs Controller General of India DCGI granted emergency use authorisation to indigenously-developed Covaxin for children above 12 years with certain conditions on FridayMore than 61 per cent of Indias adult population has received both doses of the vaccine Similarly about 90 per cent of the adult population has received the first dose of Covid vaccineThe cumulative COVID-19 vaccine doses administered in the country has exceeded 141 crore PTI PLB ANB ANB
